US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

270.46

-8.5560-3.07%

Volume:142.72K

Turnover:38.22M

Market Cap:506.98M

PE:- -

High:274.71

Open:265.00

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:2.97

T/O Rate:7.61%

Dividend:1.00

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

Avicanna Expands MyMedi.ca Platform with Integrated Medical Cannabis Program in Canadian Healthcare

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioLife Solutions (BLFS) and Corbus Pharmaceuticals (CRBP)

Autolus Receives FDA Regenerative Medicine Advanced Therapy Designation for Obecabtagene Autoleucel

MT Newswires Live

Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures

Health Care Roundup: Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":270.464,"timestamp":1789050598136,"preClose":279.02,"halted":0,"volume":142715,"delay":0,"changeRate":-0.030664468496881887,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":-8.556,"latestTime":"09-10 10:30:27 EDT","open":265,"high":274.705,"low":260.01,"amount":38215120.9402,"amplitude":0.052666,"askPrice":271.5,"askSize":1,"bidPrice":270.28,"bidSize":130,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":292.443,"aum":548181239.8,"dividendRate":0.003714,"bidAskSpread":0.003029,"preHourTrading":{"tag":"盘前","latestPrice":268.99,"preClose":279.02,"latestTime":"09:29 EDT","volume":1828,"amount":503835.0052,"timestamp":1789046962415,"change":-10.03,"changeRate":-0.035947,"amplitude":0.054249},"postHourTrading":{"tag":"盘后","latestPrice":278.58,"preClose":279.02,"latestTime":"19:59 EDT","volume":5408,"amount":1506106.6336,"timestamp":1788998373887,"change":-0.44,"changeRate":-0.001577,"amplitude":0.005304},"volumeRatio":2.969815,"impliedVol":0.9286,"impliedVolPercentile":0.5697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.969815,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":270.464,"committee":0.984733,"eps":0,"divideRate":0.003714,"volume":142715,"delay":0,"ttmEps":0,"open":265,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666970533","title":"Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666970533","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666970533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957000,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  09, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd.(NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358646/0/en/quantum-biopharma-ltd-nasdaq-qntm-receives-fda-clearance-to-begin-trials-for-historic-ms-treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","03160","ONEQ","JEPQ","QDTE","QID","TQQY","BK4007","NQmain","NVIW.SI","TM","QQQ","QQQM","BK4555","TQQQ","IYW","BK4099","QNTM","BK4588","GPIQ","FTEC","PSQ","SQQQ","MNQmain","QQQA","BK4585","TECS","NDX","03086",".IXIC","LABU","QQQY","QQQJ","BK4604","QYLG","QQQE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533180","title":"Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533180","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533180?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957000,"startTime":"0","endTime":"0","summary":"Submission package includes Method Comparison Study, which delivered accuracy above 98%, sensitivity above 94%, and 100% specificity across three independent U.S. clinical sitesNEW YORK, Sept.  09, 20","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358636/0/en/intelligent-bio-solutions-submits-fda-510-k-package-for-intelligent-fingerprinting-drug-screening-system-seeking-u-s-market-clearance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666090538","title":"Avicanna Expands MyMedi.ca Platform with Integrated Medical Cannabis Program in Canadian Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666090538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666090538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:16","pubTimestamp":1788956189,"startTime":"0","endTime":"0","summary":"An announcement from Avicanna ( ($TSE:AVCN) ) is now available. Avicanna has launched the MyMedi.ca Integrated Healthcare Program in Canada to embe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avicanna-expands-mymedi-ca-platform-with-integrated-medical-cannabis-program-in-canadian-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avicanna-expands-mymedi-ca-platform-with-integrated-medical-cannabis-program-in-canadian-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSOX","XLV","LU0128526141.USD","HCSG","BK4588","LU0029874061.USD","CNBS","MJ","TOKE","MSOS","WEED","BK4585","LABU","XBI","YOLO","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666976533","title":"Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2666976533","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666976533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"– FDA authorizes extension of Symvess expiration dating from 18 months to 36 months – – Extended shelf life supported by additional stability data demonstrating Symvess continues to meet all establish","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358551/0/en/humacyte-announces-fda-authorization-extending-symvess-shelf-life-to-36-months.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","AV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533142","title":"Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533142?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"Patient dosing commenced in the DReAMzz Phase 2 dose-optimization study of IHL-42X in obstructive sleep apneaU.S. composition and methods of treatment patent granted covering IHL-42X with baseline exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358577/0/en/incannex-healthcare-provides-corporate-update-on-clinical-progress-intellectual-property-and-capital-position.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","XLV","BK4588","LU2065732104.USD","LU0029874061.USD","BK4137","BK4097","USRD","XBI","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547538","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: BioLife Solutions (BLFS) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:50","pubTimestamp":1788954637,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioLife Solutions (BLFS) and Corbus Pharmaceutical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-biolife-solutions-blfs-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-biolife-solutions-blfs-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1169589451.USD","XLV","LU0029874061.USD","LU0128526141.USD","BK4139","BK4198","BK4585","BLFS","CRBP","XBI","BK4137","LU1169590202.USD","HCSG","LABU","BK4581","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580908","title":"Autolus Receives FDA Regenerative Medicine Advanced Therapy Designation for Obecabtagene Autoleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580908","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580908?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:42","pubTimestamp":1788954145,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics (AUTL) said Wednesday that the US Food and Drug Administration has granted regenerative medicine advanced therapy designation for obecabtagene autoleucel to treat systemic lupus e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2931357623.SGD","BK4139","AUTL","BK4588","LU1815336091.USD","IE00B66KJ199.SGD","IE0031619046.USD","LU0757428866.USD","LU2089985449.USD","IE00B7SZL793.SGD","LABU","AEIS","BK4157","IE00B19Z4B17.USD","LU0274383776.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666796587","title":"Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2666796587","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666796587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952531,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics (AUTL) announced that the FDA has granted regenerative medicine advanced therapy, or RMAT, designation to obecabtagene autoleu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LENZ","AUTL","LABU","BK4139","BK4539","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666769587","title":"Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666769587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666769587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952232,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Collegium Pharmaceutical (COLL), Revolution Medicine...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-collegium-pharmaceutical-coll-revolution-medicines-rvmd-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B4R5TH58.HKD","LU0889565916.HKD","COLL","BK4588","XBI","BK4556","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4007","LU0029874061.USD","BK4535","BK4137","CANC","IDNA","IE00BFTCPJ56.SGD","IE0009355771.USD","NTLA","RVMD","LU1861559042.SGD","IE00BJJMRZ35.SGD","LABU","XLV","BBH","PTH","HCSG","IE0009354923.USD","LU1861558580.USD","BK4585","LU0320765992.SGD","BK4581","LU0109394709.USD","IE0002141913.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666941587","title":"Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666941587","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666941587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Enrollment in LUMINA, the pivotal Phase 2 study of obe-cel in refractory lupus nephritis, is ongoingLONDON and GAITHERSBURG, Md., Sept.  09, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358486/0/en/autolus-therapeutics-announces-fda-rmat-designation-granted-to-obe-cel-for-the-treatment-of-systemic-lupus-erythematosus-and-lupus-nephritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4110","BK4139","LABU","BK4588","BK4007","SLE","BK4585","BK4077","BK4539","ACR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587949","title":"Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587949","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587949?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"OPGx-BEST1 demonstrated a favorable safety and tolerability profile with no serious adverse events or dose-limiting toxicities observed All five participants demonstrated clinically meaningful improve","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358458/0/en/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-1-2-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","NVIB","MEDX","GDOC","ARB","IDNA","LABU","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587934","title":"Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587934?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoing, with a high participation rate and several indicators of improved glycemic control, including a n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358488/0/en/rezolute-provides-update-on-fda-review-of-its-phase-3-sunrize-study-results-in-congenital-hyperinsulinism.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154778.USD","BK4213","BK4585","BK4588","LU0029874061.USD","LU2360032135.SGD","HI","SOC","LABU","LU2125154935.USD","LU0128526141.USD","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458794","title":"X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458794","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458794?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  09, 2026  -- X4 Pharmaceuticals , a company focused on improving the lives of people with rare hematology diseases, today announced that management will participate in a fireside chat at the 2026 Wells Fargo Healthcare Conference on Thursday, September 10, 2026 at 9:30 a.m. ET. A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: Events and Presentations. About X4 Pharmaceuticals X4 Pharmaceuticals is a company focused on improving the lives of people with rare hematology diseases by developing and commercializing innovative therapies in areas with significant unmet needs. Leveraging expertise in diseases of the immune system and CXCR4 biology, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is commercially available in the U.S. as XOLREMDI in its first indication. The Company is currently conducting a global, pivotal Phase 3 clinical trial  evaluating mavorixafor in chron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358482/0/en/x4-pharmaceuticals-to-participate-in-a-fireside-chat-at-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU2361045086.USD","XBI","BK4559","LU0980610538.SGD","LU1506573853.SGD","LU0477156953.USD","BK4582","LU1267930227.SGD","LU0251142724.SGD","FTXO","LU0942090050.USD","LU1074936037.SGD","LU0029874061.USD","LU2461242641.AUD","LU0310800379.SGD","LU0320765489.SGD","PGF","LU0208291251.USD","IYF","LU0251131958.USD","LU0267386448.USD","LU0314106906.USD","LU1791807156.HKD","LU0708994859.HKD","TFNS","LU0640476718.USD","LU1668664300.SGD","KBWB","LU0310800965.SGD","LU0048573561.USD","LU0868494617.USD","LU0149725797.USD","LU0029864427.USD","LABU","LU0130517989.USD","LU0175139822.USD","LU0072461881.USD","XLV","LU2236285917.USD","LU0211328371.USD","HCSG","LU0417517546.SGD","LU1894683264.USD","BK4585","BK4504","IE000M9KFDE8.USD","LU0128525689.USD","BK4581","LU1267930490.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587822","title":"Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587822?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:50","pubTimestamp":1788951011,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Assembly Biosciences (ASMB), Waters (WAT) and Amge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU0058720904.USD","LU2404859741.USD","LU1023059063.AUD","SG9999001440.SGD","IBBQ","PJP","LU0347712357.USD","BK4533","LU2242652126.USD","BK4139","BK4581","BIB","BK4585","LU2404859667.USD","LU0109394709.USD","XBI","LU0029874061.USD","LU2242646821.SGD","AMGN","LU1983299246.USD","LABU","GB00B4QBRK32.GBP","XLV","IE00B4R5TH58.HKD","BBH","LU2112291526.USD","LU0868494617.USD","LU2468319806.SGD","LU0122379950.USD","LU2089984988.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4588","LU1061106388.HKD","BK4121","BK4566","IE00B2B36J28.USD","LU0690374961.EUR","LU0889565916.HKD","LU1721428933.USD","PBE","LU2413666699.HKD","LU0728928796.USD","IBB","ASMB","GB00B4LPDJ14.GBP","LU0320765992.SGD","HCSG","WAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828455","title":"Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828455","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828455?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358431/0/en/telix-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-and-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710582.SGD","IAI","LU1989772923.USD","LU2089283258.USD","BK4588","LU0098860793.USD","LU2487616109.SGD","BK4504","HCSG","LU0128526141.USD","LU1244550494.USD","ASX","LU0390134368.USD","LU1732800096.USD","LU1074936037.SGD","LU1244550221.USD","LU0314104364.USD","BK4516","BK4534","LU1720051017.SGD","IE00BZ1G4Q59.USD","KBWB","BK4127","IE00BKVL7J92.USD","LU0557290698.USD","LU2347655156.SGD","LU0225283273.USD","BK4141","LU0158827948.USD","IE00B775SV38.USD","LU0795875086.SGD","LU0267386448.USD","TLX","XBI","XLV","LU1162221912.USD","BK4137","LU1668664300.SGD","LU0053666078.USD","LU0106831901.USD","LU0006306889.USD","LU1064131342.USD","LU0106261372.USD","LU2028103732.USD","LABU","LU1363072403.SGD","LU0158827781.USD","LU0234570918.USD","MS","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582590","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582590?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:20","pubTimestamp":1788949241,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (ABT), Pharvaris (PHVS) and Zi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0432979614.USD","LU1201861249.SGD","LU0114720955.EUR","LU1267930573.SGD","LU0130102774.USD","LU1023059063.AUD","LU2089984988.USD","LU1670628061.USD","LU0211327993.USD","ZBH","BK4504","LU0234572021.USD","SGXZ23171101.USD","XLV","LU1691799644.USD","PJP","LU0882574055.USD","LU2211815571.USD","TMED","IHI","LABU","IE00B2B36J28.USD","IE00B19Z3581.USD","LU0310799852.SGD","LU0708994859.HKD","LU2133065610.SGD","LU0128526141.USD","LU2468319806.SGD","LU0211328371.USD","LU0648001328.SGD","IE0002270589.USD","IE00BJT1NW94.SGD","BK4007","LU1061106388.HKD","HCSG","ABT","BK4082","IE00B19Z3B42.SGD","LU1914381329.SGD","LU1989763690.USD","BK4592","LU0029864427.USD","LU0980610538.SGD","PHVS","LU0320765489.SGD","BK4585","XBI","LU0170899867.USD","LU2237957811.SGD","LU0889566641.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582848","title":"RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582848?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:00","pubTimestamp":1788948000,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Sept.  09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358410/10985/en/radnet-inc-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-on-wednesday-september-16th-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","XBI","BK4581","BK4196","XLV","HCSG","BK4137","LU0128526141.USD","BK4585","RDNT","BK4588","LU2065731478.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584832","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584832?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:50","pubTimestamp":1788947417,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Surrozen (SRZN), Liquidia Technologies (LQDA) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRZN","BK4585","BK4185","LU0128526141.USD","XBI","LQDA","LU0029874061.USD","BK4139","XLV","BK4007","HCSG","BK4137","BK4581","UHS","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589965","title":"Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589965","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:11","pubTimestamp":1788945080,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has issued an update. Bamboos Health Care Holdings Ltd has issued a profit warning, indicating net ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158565","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158565?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:20","pubTimestamp":1788942000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0801 GMT - Novartis's latest clinical-trial setback raises quest","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","BK4585","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":3,"totalSize":411,"code":"91000000","status":"200"}]}}